The workplace project – putting learning into practice

We want our education to be impactful, transforming an individual's practice - and through that, the team or service they work within. Intermodule projects are a core part of the education we offer, providing an opportunity to reinforce learning, test new knowledge and skills and improve local services.

Attendees have free reign over their project which must meet a local need, and they present their work back to their peers at module two of the course, and the class chooses a winning project.

We believe that one of the best ways to learn something is from others who have already learned it. We'd encourage you to have a look through the extensive 'back catalogue' of previous projects to find one addressing a similar need to the one in your area, or to learn how others have overcome obstacles you might face.

'Workplace projects give a space for the MasterClass's challenging learning outcomes to change things at a grassroots level and then to keep changing them - and this is what makes a difference to people with Parkinson’s.’
Dr Peter Fletcher, academic director emeritus, Parkinson's Academy


Spotlight projects


Siponimod use in Northern Ireland
By Conor Hughes, Clinical fellow, Royal Victoria Hospital
Empowering health visitors: maximizing SMA recognition, referral, and treatment outcomes through educational initiative
By Dr Ushma Patel. clinical fellow in paediatric neurology, University Hospitals of Leicester NHS Trust & Yvonne Julien, neuromuscular care advisor, University Hospitals of Leicester NHS Trust
Development of a frailty memory service
By Dr Michelle McCarthy, Consultant community geriatrician, Countess Of Chester Hospital NHS Foundation Trust

All projects


Showing 91-100 of 107 projects

Time from ‘treatment decision’ to ‘actual start of DMT’ in MS – a local clinical survey
By Dr Bindu Yoga, Consultant Neurologist, Mid Yorkshire Hospitals NHS Trust
Audit of safe monitoring of MS patients on natalizumab
By Dr Lewis Kass-lliyya, Dr Jennifer Hosty and Dr Simon Bell, Royal Hallamshire Hospital (Supervisor: Dr David Paling)
Fingolimod safety considerations in real-world practice: fingolimod-associated macular oedema (FAME)
By Dr Paul Gallagher and Dr Sarah-Jane Martin, Institute of Neurological Sciences, Glasgow
Listeriosis prevention in alemtuzumab treated patients
By Dr Rachelle Shafei, Clinical Research Fellow, University College London
JCV in Jersey
By Dr Jessica Vaz, Associate Specialist, Jersey General Hospital
Impact of a pharmacy-led prescribing service on the monitoring of natalizumab patients
By Rachel Dorsey-Campbell, Senior Lead Pharmacist, Neurosciences, Imperial College Healthcare NHS Trust
Multiple Sclerosis Case study & Use of DMT in West Berkshire
By Dr Peter Khin Tun, MBBS, MRCP(UK), Associate Specialist in Neurological Rehabilitation Medicine, Royal Berkshire Hospital
Audit of DMT prescribing practices at South Tees Hospitals
By Dr Adrienn Petreczky, James Cook University Hospital, Middlesbrough